Metraipolis › archive › dc_7e810baca7a4

Tumor microenvironment-activated ferritin nanovector enables enhanced tumor delivery of KRASG12C inhibitors and degraders — Europe PMC PMID:41822354

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41822354
DOI
10.3389/fcell.2026.1725088
License (as archived)
solo-consultazione
Archived
2026-11-05T12:19:28.278Z
SHA-256 of the archived text
8f8b357da4e3b75e74482343de0f5c66f99f9e4f6a046968040d01f8c5860ef6
Stable URL of this page
https://metraipolis.com/documento/dc_7e810baca7a4

How to cite

Tumor microenvironment-activated ferritin nanovector enables enhanced tumor delivery of KRASG12C inhibitors and degraders — Europe PMC PMID:41822354 — Europe PMC (en), https://europepmc.org/article/MED/41822354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e810baca7a4 (Metraipolis archive dc_7e810baca7a4, sha256 8f8b357da4e3b75e74482343de0f5c66f99f9e4f6a046968040d01f8c5860ef6)
BibTeX
@misc{dc7e810baca7a4,
  title = {Tumor microenvironment-activated ferritin nanovector enables enhanced tumor delivery of KRASG12C inhibitors and degraders — Europe PMC PMID:41822354},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41822354},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e810baca7a4; sha256 8f8b357da4e3b75e74482343de0f5c66f99f9e4f6a046968040d01f8c5860ef6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822354. Agents can read the archived copy with the MCP tool read_document.